Quanterix (QTRX)

• Market cap: $148M
• 1 day: -3.07%
• 5 days: -9.2%
• 1 month: -19.8%
• 3 months: -51.23%
• 6 months: -46.08%
• Year to date: -50.86%
• 1 year: -40.82%
• 5 years: -94.8%
• 10 years: -81.91%
• Sector: Healthcare
• Industry: Medical Devices

About: Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Employees: 450